PRLD icon

Prelude Therapeutics
PRLD

Overview Fund Activity

62 hedge funds and large institutions have $41M invested in Prelude Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 16 closing their positions.

Holders
62
Holders Change
-8
Holders Change %
-11.43%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
26
Reduced
12
Closed
16
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$850K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$809K
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$617K
4
Millennium Management
4
Millennium Management
New York
$590K
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$383K

Top Sellers

1
DM
1
Deerfield Management
New York
$0
2
ECM
2
ExodusPoint Capital Management
New York
$0
3
APM
3
Avidity Partners Management
Texas
$0
4
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$0
5
Walleye Capital
5
Walleye Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AAP
76
Arax Advisory Partners
Colorado
– – -19 Closed
CPA
77
Capital Performance Advisors
California
– – -8 Closed
AB
78
Amalgamated Bank
New York
$0 334 – –
CFGS
79
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4